Fei Yu

2.7k total citations
92 papers, 2.2k citations indexed

About

Fei Yu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Fei Yu has authored 92 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 22 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Fei Yu's work include RNA Interference and Gene Delivery (14 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Fei Yu is often cited by papers focused on RNA Interference and Gene Delivery (14 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Fei Yu collaborates with scholars based in China, United States and South Africa. Fei Yu's co-authors include David Oupický, Jing Li, Ying Xie, Chengzhi Cai, Xiao Dong Chen, Zhenqing Hou, Jiahong Dong, Yi Chen, Daosheng Huang and Hongli Zheng and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Fei Yu

88 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Yu China 27 992 389 370 363 263 92 2.2k
Imran Vhora India 21 877 0.9× 386 1.0× 325 0.9× 617 1.7× 216 0.8× 25 1.8k
Rui Sun China 24 825 0.8× 489 1.3× 201 0.5× 499 1.4× 133 0.5× 86 2.0k
Hamidreza Montazeri Aliabadi United States 24 1.1k 1.1× 285 0.7× 302 0.8× 778 2.1× 380 1.4× 64 2.4k
Houría Boulaiz Spain 28 928 0.9× 406 1.0× 332 0.9× 383 1.1× 194 0.7× 84 2.0k
Chaofeng Mu China 24 929 0.9× 602 1.5× 399 1.1× 684 1.9× 128 0.5× 53 2.0k
Ke Men China 32 1.1k 1.1× 547 1.4× 299 0.8× 882 2.4× 308 1.2× 82 2.7k
Ommoleila Molavi Iran 27 1.3k 1.3× 373 1.0× 507 1.4× 541 1.5× 251 1.0× 73 2.7k
Hui Xue China 27 1.6k 1.6× 570 1.5× 333 0.9× 726 2.0× 198 0.8× 101 2.9k
Ting Zhong China 23 975 1.0× 318 0.8× 202 0.5× 451 1.2× 116 0.4× 107 2.0k
Maryam Hashemi Iran 33 1.4k 1.4× 679 1.7× 374 1.0× 829 2.3× 221 0.8× 132 3.2k

Countries citing papers authored by Fei Yu

Since Specialization
Citations

This map shows the geographic impact of Fei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yu more than expected).

Fields of papers citing papers by Fei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yu. The network helps show where Fei Yu may publish in the future.

Co-authorship network of co-authors of Fei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Yu. A scholar is included among the top collaborators of Fei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Yu. Fei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Dongsheng, Chang Liu, Bin Yang, et al.. (2025). Metagenomic fingerprints in bronchoalveolar lavage differentiate pulmonary diseases. npj Digital Medicine. 8(1). 599–599.
2.
Hu, Xiwen, Na Li, Limin Xu, et al.. (2024). Kidney targeted delivery of siRNA mediated by peptide-siRNA conjugate for the treatment of acute kidney injury. Chinese Chemical Letters. 36(6). 110251–110251. 2 indexed citations
3.
Hou, Xin, Fei Yu, Chang Liao, et al.. (2024). Preparation and characterization of solution deposition planarized Y2O3–Al2O3 compound seed layer for coated conductors. Journal of Materials Science Materials in Electronics. 35(18). 1 indexed citations
4.
Wang, Man, Fei Yu, & Peifeng Li. (2023). Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities. Frontiers in Immunology. 14. 1269054–1269054. 29 indexed citations
5.
Yu, Fei, et al.. (2023). CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7/c-Myc-dependent axis. Biochemical Pharmacology. 209. 115446–115446. 13 indexed citations
6.
Han, Yi, Huihui Shi, Fei Yu, et al.. (2021). Engineered bio-adhesive polyhedral oligomeric silsesquioxane hybrid nanoformulation of amphotericin B for prolonged therapy of fungal keratitis. Chemical Engineering Journal. 421. 129734–129734. 26 indexed citations
7.
Yu, Fei, et al.. (2021). A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(10). 963–975. 2 indexed citations
8.
Wu, Lingli, et al.. (2020). An association analysis for genetic factors for dental caries susceptibility in a cohort of Chinese children. Oral Diseases. 28(2). 480–494. 14 indexed citations
9.
Liu, Jingwen, Fei Yu, Jian-Ping Huo, et al.. (2020). Profiling of Tumor Microenvironment Components Identifies Five Stroma-Related Genes with Prognostic Implications in Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(10). 882–892. 16 indexed citations
10.
Yu, Fei, et al.. (2019). Synthesis and biological characterization of clicked chloroquine copolymers as macromolecular inhibitors of cancer cell migration. Journal of Polymer Science Part A Polymer Chemistry. 57(22). 2235–2242. 8 indexed citations
11.
Yu, Fei, et al.. (2019). Long-Term Efficacy of Laparoscopic Radiofrequency Ablation in Early Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(6). 770–779. 8 indexed citations
12.
Zhou, Yiwen, Fei Yu, Feiran Zhang, et al.. (2018). Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer. Biomacromolecules. 19(2). 392–401. 35 indexed citations
13.
Chen, Gang, Yixin Wang, Pengkai Wu, et al.. (2018). Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer. ACS Nano. 12(7). 6620–6636. 50 indexed citations
14.
Wu, Pengkai, et al.. (2018). Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)‐Based CXCR4 Antagonists. Macromolecular Bioscience. 18(11). e1800234–e1800234. 11 indexed citations
15.
Chen, Gang, Kaikai Wang, Qi Hu, et al.. (2017). Combining Fluorination and Bioreducibility for Improved siRNA Polyplex Delivery. ACS Applied Materials & Interfaces. 9(5). 4457–4466. 53 indexed citations
16.
Wang, Ye, et al.. (2017). Isolation and Characterization of a Human Intestinal Bacterium Eggerthella sp. AUH-JLD49s for the Conversion of (−)-3′-Desmethylarctigenin. Journal of Agricultural and Food Chemistry. 65(20). 4051–4056. 5 indexed citations
17.
Sleightholm, Richard, et al.. (2017). Chloroquine-Modified Hydroxyethyl Starch as a Polymeric Drug for Cancer Therapy. Biomacromolecules. 18(8). 2247–2257. 47 indexed citations
18.
19.
Xie, Ying, Tracy Murray Stewart, Yazhe Wang, et al.. (2016). Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy. Journal of Controlled Release. 246. 110–119. 82 indexed citations
20.
Li, Jing, Fei Yu, Yi Chen, & David Oupický. (2015). Polymeric drugs: Advances in the development of pharmacologically active polymers. Journal of Controlled Release. 219. 369–382. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imran Vhora Breakdown of academic impact, for papers by Rui Sun Breakdown of academic impact, for papers by Hamidreza Montazeri Aliabadi Breakdown of academic impact, for papers by Houría Boulaiz Breakdown of academic impact, for papers by Chaofeng Mu Breakdown of academic impact, for papers by Ke Men Breakdown of academic impact, for papers by Ommoleila Molavi Breakdown of academic impact, for papers by Hui Xue Breakdown of academic impact, for papers by Ting Zhong Breakdown of academic impact, for papers by Maryam Hashemi
Rankless by CCL
2026